BGNE:ADS (Sponsored) Repstg Shs/BeiGene Ltd - Stock Price Quote and Dividend Data
BGNE STOCK PRICE LATEST CLOSE
$184.71
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
ADS (Sponsored) Repstg Shs/BeiGene Ltd Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
ADS (Sponsored) Repstg Shs/BeiGene Ltd Stock Price Information
52-Week Low/High Stock Price$126.97 - $248.16
Percent Held by Institutions51.55%
Revenue$4,318,425,000
Net Income$-981,808,000
Cash Flow$-249,060,000
EPS-0.09%
Market Cap$0
PE Ratio to Industry51%
Debt-Equity Ratio30.60%
Debt-Equity to Industry1.33%
Total Return Last 12 Months2.41%
Total Return Last 3 Years-31.82%
Total Return Last 5 Years11.43%
Latest Trade DateDec. 31, 2024
ADS (Sponsored) Repstg Shs/BeiGene Ltd Annual Stock Dividends
No Data available for Payment History.
ADS (Sponsored) Repstg Shs/BeiGene Ltd Dividend Payment History
| No dividends retrieved for BGNE |
ADS (Sponsored) Repstg Shs/BeiGene Ltd Other Dividend Details
BeiGene is a commercial-stage biotechnology company focused on developing and commercializing molecularly-targeted and immuno-oncology cancer therapeutics. Co.'s clinical-stage drug candidates include: Zanubrutinib, which is a small molecule inhibitor of Bruton's tyrosine kinase for the treatment of mantle cell lymphoma in adult patients; Tislelizumab, which is a humanized monoclonal antibody against the immune checkpoint receptor programmed cell death protein 1; Pamiparib (BGB-290), which is for the treatment of various solid tumors; and Lifirafenib, which is an investigational small molecule inhibitor with RAF monomer and dimer inhibition activities.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Feb. 28, 2024BGNE STOCK PRICE INCREASE: ADS (Sponsored) Repstg Shs/BeiGene Ltd on 02-28-2024 increased stock price > 10% from $160.26 to $179.69
Apr. 07, 2023BGNE STOCK PRICE INCREASE: ADS (Sponsored) Repstg Shs/BeiGene Ltd on 04-07-2023 increased stock price > 10% from $212.00 to $238.45
Oct. 13, 2022BGNE STOCK PRICE INCREASE: ADS (Sponsored) Repstg Shs/BeiGene Ltd on 10-13-2022 increased stock price > 10% from $125.51 to $151.30
Aug. 05, 2022BGNE STOCK PRICE INCREASE: ADS (Sponsored) Repstg Shs/BeiGene Ltd on 08-05-2022 increased stock price > 10% from $169.72 to $191.08
Jul. 06, 2022BGNE STOCK PRICE INCREASE: BeiGene Ltd on 07-06-2022 increased stock price > 10% from $166.95 to $194.48
Jun. 25, 2022BGNE STOCK PRICE INCREASE: BeiGene Ltd on 06-25-2022 increased stock price > 10% from $156.20 to $177.99
Jun. 22, 2022BGNE STOCK PRICE INCREASE: BeiGene Ltd on 06-22-2022 increased stock price > 10% from $132.14 to $152.67
Jun. 14, 2022BGNE STOCK PRICE DECREASE: BeiGene Ltd on 06-14-2022 decreased stock price > 10% from $147.47 to $130.30
Jun. 08, 2022BGNE STOCK PRICE INCREASE: BeiGene Ltd on 06-08-2022 increased stock price > 10% from $138.43 to $154.57
Mar. 17, 2022BGNE STOCK PRICE INCREASE: BeiGene Ltd on 03-17-2022 increased stock price > 10% from $146.52 to $183.33
Apr. 11, 2025DIVIDEND RATE INCREASE: ADR (Sponsored)/CSL Ltd (OTCBB: CSLLY) on 04-11-2025 increased dividend rate > 3% from $1.22 to $1.28
Apr. 11, 2025KRBPQ STOCK PRICE DECREASE: Kiromic BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.12 to $0.08
Apr. 11, 2025OMGAQ STOCK PRICE DECREASE: Omega Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $0.05 to $0.04
Apr. 11, 2025ALGS STOCK PRICE DECREASE: Aligos Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $5.03 to $3.99
Apr. 11, 2025ATRA STOCK PRICE DECREASE: Atara Biotherapeutics Inc on 04-11-2025 decreased stock price > 10% from $5.89 to $5.30
Apr. 11, 2025ZVSA STOCK PRICE DECREASE: Com Par $0.001/ZyVersa Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $1.03 to $0.77
Apr. 11, 2025GERNW STOCK PRICE DECREASE: Wt Pur Com Exp 12/31/2025/Geron Corp. on 04-11-2025 decreased stock price > 10% from $0.30 to $0.27
Apr. 11, 2025RVMDW STOCK PRICE DECREASE: Wt Exp/Revolution Medicines Inc on 04-11-2025 decreased stock price > 10% from $0.05 to $0.03
Apr. 11, 2025ELUT STOCK PRICE DECREASE: Cl A Com/Elutia Inc on 04-11-2025 decreased stock price > 10% from $2.49 to $2.24
Apr. 11, 2025QNRX STOCK PRICE DECREASE: Sponsored ADR (New)/Quoin Pharmaceuticals Ltd on 04-11-2025 decreased stock price > 10% from $6.89 to $5.49
